Radient Pharmaceuticals is a company dedicated to improving lives in the world overall, especially the lives of people with cancer. We specialize in the development, manufacturing and delivery of innovative, safe and effective In Vitro Diagnostic tests for the screening, monitoring and detection of 19 different types of cancer.
Our commitment is to provide new technologies and products that address serious health challenges worldwide. Our products are currently available in all 5 continents.
A big priority here at Radient is delivering a return to the employees, partners and shareholders who believe in and support what we do each and every day – returns that demonstrate strong company and market performance.
Our wholly-owned subsidiary is AMDL Diagnostics Inc., which develops, owns, manufactures, and markets our IVD technology out of our Tustin, California, facility.